Clinical Trial Update: Randomized Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophthalmic Solution, 0.5% [Phase 3]

View source ↗

Summary

Phase 3 randomized study comparing two travoprost intraocular implant models to timolol maleate ophthalmic solution 0.5%; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• Timolol maleate ophthalmic solution 0.5% (timolol maleate ophthalmic solution 0.5%)
• Travoprost intraocular implant (travoprost)

Snippet

Sponsor: Glaukos Corporation | Conditions: Glaucoma, Open-Angle, Ocular Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2023-09-14